MedPath

SAR-125844

Generic Name
SAR-125844
Drug Type
Small Molecule
Chemical Formula
C25H23FN8O2S2
CAS Number
1116743-46-4
Unique Ingredient Identifier
XH93U6NIJE
Background

SAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors).

Clinical Trials
Related News

A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification

Phase 2
Completed
Conditions
Neoplasm Malignant
Interventions
First Posted Date
2015-05-06
Last Posted Date
2016-03-23
Lead Sponsor
Sanofi
Target Recruit Count
1
Registration Number
NCT02435121
Locations
๐Ÿ‡ง๐Ÿ‡ช

Investigational Site Number 056001, Edegem, Belgium

Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients

Phase 1
Completed
Conditions
Neoplasm Malignant
Interventions
First Posted Date
2012-08-06
Last Posted Date
2016-02-17
Lead Sponsor
Sanofi
Target Recruit Count
70
Registration Number
NCT01657214
Locations
๐Ÿ‡ฏ๐Ÿ‡ต

Investigational Site Number 392001, Kashiwa-Shi, Japan

๐Ÿ‡ฏ๐Ÿ‡ต

Investigational Site Number 392004, Suita-Shi, Japan

๐Ÿ‡ฏ๐Ÿ‡ต

Investigational Site Number 392002, Sunto-Gun, Japan

and more 5 locations

Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors

Phase 1
Completed
Conditions
Malignant Solid Tumors
Interventions
First Posted Date
2011-07-12
Last Posted Date
2016-04-13
Lead Sponsor
Sanofi
Target Recruit Count
72
Registration Number
NCT01391533
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Investigational Site Number 840001, Boston, Massachusetts, United States

๐Ÿ‡ฎ๐Ÿ‡น

Investigational Site Number 380001, Milano, Italy

๐Ÿ‡ซ๐Ÿ‡ท

Investigational Site Number 250002, Dijon, France

and more 5 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy